Maternal Syphilis: An Independent Risk Factor for Mother to Infant Human Immunodeficiency Virus Transmission

Sex Transm Dis. 2017 Jun;44(6):371-375. doi: 10.1097/OLQ.0000000000000622.

Abstract

Syphilis is associated with increased human immunodeficiency virus acquisition and sexual transmission; we examined impact on human immunodeficiency virus mother-to-child transmission among mother-infant pairs enrolled in the India Six-Week Extended-Dose Nevirapine study. Maternal syphilis, diagnosed serologically using Venereal Disease Research Laboratory titer plus Treponema Pallidum Hemagglutination Assay, was associated with 2.5-fold greater risk.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use
  • CD4 Lymphocyte Count
  • Clinical Trials, Phase III as Topic
  • Cost-Benefit Analysis
  • Female
  • Follow-Up Studies
  • HIV Infections / epidemiology
  • HIV Infections / transmission*
  • HIV-1
  • Humans
  • India / epidemiology
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical / prevention & control
  • Infectious Disease Transmission, Vertical / statistics & numerical data*
  • Male
  • Mothers
  • Nevirapine / therapeutic use
  • Point-of-Care Testing* / economics
  • Pregnancy
  • Pregnancy Complications, Infectious / diagnosis
  • Pregnancy Complications, Infectious / epidemiology*
  • Prenatal Care
  • Prenatal Education / organization & administration
  • Randomized Controlled Trials as Topic
  • Syphilis / diagnosis
  • Syphilis / epidemiology*
  • Syphilis Serodiagnosis* / economics
  • Viral Load
  • Young Adult

Substances

  • Anti-HIV Agents
  • Nevirapine